247 results
Page 7 of 13
8-K
EX-10.4
6wztw v65yg
31 Dec 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
jcojhzn9njicq yu6e
31 Dec 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
81ptn4so
26 Oct 15
Entry into a Material Definitive Agreement
12:00am
8-K
tx63l4yn57upjw
26 Oct 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
m8njfgm3
24 Feb 15
NeoGenomics Reports Record Revenue of $25.0 Million, Adjusted EBITDA of $2.8 MM and Net Income of $0.02 per Share for the Fourth Quarter 2014
12:00am
8-K
EX-99.1
uwp auugli
23 Jan 15
Company Now Projecting 36% Year-Over-Year Revenue Growth in Quarter 4
12:00am
8-K
EX-99.1
h141kwbt6mce 0jv
30 Oct 14
NeoGenomics Reports 38% increase in Revenue to a Record $23.2 Million and Adjusted EBITDA of $2.6 Million for the Third Quarter of 2014
12:00am
8-K
EX-99.1
zdqmyavno9gly6cxtb
17 Oct 14
Charter of the Compliance Committee
12:00am
8-K
EX-10.2
st7z 45t393ebsjffx6
3 Oct 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-1.1
gghrmdh7
15 Aug 14
NeoGenomics Announces Pricing of $32.2 Million Public Offering
12:00am
424B5
xplexwiw410lltxrn0
15 Aug 14
Prospectus supplement for primary offering
12:00am
8-K
97tcfv6
15 Aug 14
NeoGenomics Announces Pricing of $32.2 Million Public Offering
12:00am
8-K
EX-99.1
s7nc 4bkkf
17 Jul 14
NeoGenomics Reports Record Revenues of $20.7 Million on 40% Test Volume Growth and Expanding Gross Margins for the Second Quarter 2014
12:00am